Article
Somatic cell gene therapy for diabetes mellitus : engineering a surrogate B-cell
1996-01-01
Abstract excerpt
Improved methods of insulin delivery are required for the treatment of insulin-dependent diabetes mellitus (IDDM) to achieve a more physiological profile of glucose homeostasis. Somatic cell gene therapy offers the prospect that insulin could be delivered by an autologous cell implant, engineered to secrete insulin in response to glucose. This study explores the feasibility of manipulating somatic cells to behave...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0f978956-0cc9-548a-8526-bded6e8cb5da
- DOI
- 10.48780/publications.aston.ac.uk.00010940
